Five Prime Thera (FPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | |
| Sales | 23,740 |
| Gross Profit | 23,740 |
| Operating Expenses | 37,755 |
| Operating Income | -14,015 |
| Other Income | 549 |
| Pre-tax Income | -13,466 |
| Income Tax | -5 |
| Net Income Continuous | -13,461 |
| Net Income | $-13,461 |
| EPS Basic Total Ops | -12.22 |
| EPS Basic Continuous Ops | -12.22 |
| EPS Diluted Total Ops | -12.22 |
| EPS Diluted Continuous Ops | -12.22 |
| EBITDA(a) | $-12,231 |